Corvus Pharmaceuticals, Inc. (CRVS)
16.57
-0.96
(-5.48%)
USD |
NASDAQ |
Feb 20, 16:00
16.53
-0.04
(-0.24%)
After-Hours: 20:00
Corvus Pharmaceuticals SG&A Expense (Quarterly) : 2.118M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Plus Therapeutics, Inc. | 3.443M |
| Geron Corp. | 39.00M |
| Jaguar Health, Inc. | 6.131M |
| Krystal Biotech, Inc. | 41.45M |